Orbit summarizes health news from several newsrooms. It is not medical advice. Talk to a doctor or pharmacist about your own health.
At a glance
The FDA has issued a warning stating that GLP-1 drugs carry a potential risk of a rare eye condition.1234
According to reporting on the advisory, the rare condition carries a risk of vision loss.12
The warning applies to the class of medications known as GLP-1s.1234
Where sources agree
- FDA warned of rare eye condition risk from GLP-1s4 of 4
- The eye condition carries a risk of vision loss2 of 4
Who covered this
4 National
Sources
- 1Ars TechnicaFDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss ↗
- 2CNBCFDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound ↗
- 3STATSTAT+: GLP-1s are given an FDA warning for rare eye condition risk ↗
- 4STATSTAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more ↗
Based on reporting from these reputable newsrooms and reviewed by Orbit’s editors. A fact appears only when at least two sources report it. Orbit is not affiliated with these publishers.
